Want to see IPHA full AI Analyst Report?

Innate Pharma (IPHA) Cash flow

149 Followers

Innate Pharma Cash Flow

IPHA's free cash flow for Q2 2026 was €-21.42M. For the 2026 fiscal year, IPHA's free cash flow was decreased by €-27.62M and operating cash flow was €-21.33M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	€ -32.56M	€ -6.90M	€ -32.56M	€ -19.15M	€ -58.46M
Investing Cash Flow	€ 20.63M	€ 9.20M	€ 20.63M	€ 1.88M	€ -917.00K
Financing Cash Flow	€ -1.97M	€ -6.01M	€ -1.97M	€ -1.83M	€ 26.82M
End Cash Position	€ 70.61M	€ 66.40M	€ 70.61M	€ 84.22M	€ 103.76M
Free Cash Flow	€ -34.91M	€ -7.29M	€ -34.91M	€ -20.28M	€ -59.79M

Currency in EUR